Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get in-depth healthcare industry analysis with the unparalleled resources at Informa Pharma Intelligence.
Follow the evolution of the Zolgensma story and examine its possible implications for the future of product approval procedures.
Your free Pink Sheet pack includes:
The 2019 Titan of Pharma infographic is a snapshot of the industry’s top leaders and the businesses they oversee, including:
Pharma R&D Annual Review 2019 is based on the stats and data from Pharmaprojects, part of Informa’s Citeline family of intelligence solutions. Authored for the 27th time by Ian Lloyd, Senior Director, Pharmaprojects, this whitepaper contains the whole nine yards:
The ball is in your court: tap into the industry expertise and experience of Ian Lloyd, backed by the rock-solid data from Pharmaprojects download Pharma R&D Annual Review 2019 from Citeline, today.
Listen to our special Spotify playlist while you read. We hope you enjoy this tongue-in-cheek collection of songs, specially curated as the perfect accompaniment to the Pharma R&D Annual Review 2019.
Pharmaprojects
Using new, granular data from Pharmaprojects, part of the Citeline suite of tools, this infographic will explore: The 2020 Pipeline by Phase Top Companies Mechanisms and Targets Types of Pipeline Drugs
Pharmaprojects
Using the new, granular datapoints in Pharmaprojects, Senior Director Ian Lloyd presents his expert insights into pharma’s R&D activities over the past year and what they may mean for the pipeline during the year to come. The 27th instalment of the Annual Review, this version takes advantage of improvements to Pharmaprojects’ data granularity to bring you details on pharma R&D trends
Pink Sheet
The regulatory agency also urges qualified persons at drug companies to let the agency know as soon as possible if they are finding that the new measures are not flexible enough to deal with the current logistical challenges quickly.
Pink Sheet
Guidelines for US health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
Topic Coronavirus
Scrip
Company suspends enrolment to trials as coronavirus travel restrictions bite.
Topic Coronavirus
Scrip
News from around the biopharma sector and its efforts to meet the challenges posed by the coronavirus pandemic.
Topic Coronavirus
Skipta
Making the most of today’s pharma marketing budgets can be tricky: you’re expected to deliver more, often with fewer resources. Explore the strategies most effective for getting your product or brand in front of the right healthcare professionals (HCPs) in this free white paper from Skipta.
Skipta
Discover how others in pharma are coping with reduced budgets and the pressure to hit the right healthcare professional (HCP) targets in this data-packed infographic from Skipta.
Generics Bulletin
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Topic Coronavirus
HBW Insight
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
Topic Coronavirus
Medtech Insight
A $2.2tn coronavirus stimulus package signed into law by President Trump on 27 March will distribute billions of dollars to federal agencies – including the FDA, the CDC and the FEMA – to hasten approvals of new diagnostics, medical ventilators, respirators and other medtech supplies, conduct more testing of potential COVID-19 patients, and quickly distribute medical supplies where needed most.
Topic Coronavirus
Medtech Insight
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
Topic Coronavirus Medtech
Pharmaprojects
Gain vital insight into study feasibility, site selection, and investigator prioritization with granular data from the new Informa Pharma Intelligence Patient Proximity API. Protect yourself against costly trial delays by using it to choose the right investigators with relevant and sizable patient proximity.
Scrip
Pharmaceutical manufacturing in India is facing some early stress amid the new 21-day lock-down but both the industry and government machinery are actively engaged and working together to ensure that disruptions are minimized in the ‘pharmacy of the world.’
Topic Coronavirus
Scrip
AlloVir/Baylor, Soligenix/Hawaii and CEL-SCI/Georgia ink coronavirus collaborations, but deal-making continues in other areas as well, including Asklepios/UNC teaming on a gene therapy for Angelman syndrome and DeMelle licensing a targeted pancreatic cancer drug from Moffitt, among others.
Topic Coronavirus Medtech
Pink Sheet
03 Apr 2020
Medtech Insight
03 Apr 2020
Pink Sheet
02 Apr 2020
Pink Sheet
02 Apr 2020
Scrip
02 Apr 2020
Pink Sheet
02 Apr 2020
Generics Bulletin
02 Apr 2020
Generics Bulletin
02 Apr 2020
HBW Insight
02 Apr 2020
Scrip
02 Apr 2020
Pink Sheet
02 Apr 2020
Scrip
02 Apr 2020
HBW Insight
02 Apr 2020
Scrip
02 Apr 2020
Medtech Insight
02 Apr 2020
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
